Bausch & Lomb Corp executive Luc Bonnefoy, President of Surgical, reported tax-related dispositions of common shares tied to equity awards. On February 26, 2026, 4,404 common shares at $18.49 per share were withheld to cover tax obligations upon vesting of restricted share units, leaving 113,533 shares held directly.
On February 27, 2026, 4,311 common shares and 9,221 common shares, each at $18.30 per share, were similarly withheld to satisfy tax liabilities on vesting of restricted and performance-based restricted share units, leaving 109,222 and 100,001 common shares, respectively, held directly after these transactions.
Bausch & Lomb Corp executive Yehia Hashad reported tax-related share dispositions. On February 26–27, he had several Form 4 transactions coded "F," where common shares were withheld at prices around $18.30–$18.49 to cover tax obligations upon vesting of restricted and performance-based restricted share units. After one February 27 transaction, he held 180,041 common shares directly.
Bausch & Lomb Corp executive Robert D. Bailey reported routine share dispositions related to tax withholding on vested equity awards. On two dates, he surrendered 3,395 and 2,461 common shares, respectively, at prices of $18.49 and $18.30 per share to cover tax obligations on restricted share unit vesting, rather than selling shares on the open market. After these tax-withholding transactions, he directly holds 217,290 common shares.
Bausch & Lomb EVP and CFO Sam Eldessouky reported tax-withholding dispositions of common shares related to equity awards. On February 26–27, 2026, he delivered 15,507, 51,470 and 7,062 common shares at prices of $18.30 and $18.49 per share to satisfy tax obligations.
Footnotes explain these shares were withheld upon vesting of restricted share units and performance-based restricted share units, rather than sold in open-market transactions. Eldessouky retains a significant direct holding of Bausch & Lomb common shares after these tax-withholding events.
Bausch & Lomb Corp CEO and Chairman Brent L. Saunders reported two Form 4 transactions reflecting common shares withheld to cover taxes on restricted share units that vested. On February 26, 22,059 common shares at $18.49 per share were withheld. On February 27, an additional 24,649 common shares at $18.30 per share were withheld. These are coded as tax-withholding dispositions rather than open-market sales, and Saunders held 951,875 common shares directly after the most recent transaction.
Munsch Frederick reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corporation Senior Vice President, Controller and Chief Accounting Officer Frederick Munsch received an equity award of 18,253 common shares in the form of restricted share units. The grant was made at no cash cost to him as part of the company’s 2022 Omnibus Incentive Plan.
The RSUs are scheduled to vest in three equal installments on each of the first three anniversaries of the grant date, subject to his continued service and the plan and award agreement terms. After this award, he beneficially owns 108,484 common shares directly.
Bausch & Lomb Corp reported that President, Surgical, Luc Bonnefoy acquired 30,373 common shares through a grant of restricted share units (RSUs) at no cost per share. These RSUs vest one-third on each of the first three anniversaries of the grant date. After this award, Bonnefoy holds 117,937 common shares directly.
Bausch & Lomb Corp reported that executive Andrew J. Stewart, President, GPIC, acquired 32,710 common shares on February 25, 2026 through a grant of restricted share units (RSUs) at $0.00 per share. After this award, he holds 95,640 common shares directly.
The RSUs vest in three equal installments on each of the first three anniversaries of the grant date, generally contingent on his continued service. Once vested, these RSUs will be settled in Bausch & Lomb common shares.
Hashad Yehia reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp executive Yehia Hashad, EVP of R&D and CMO, received a grant of 35,046 restricted share units (RSUs) on common shares at a price of $0.00 per share. After this equity award, his directly held common shares total 198,906.
The RSUs were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan and are scheduled to vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to continued service and plan terms. Vested RSUs will be settled in common shares of Bausch & Lomb.
Bausch & Lomb Corp reported that EVP & Chief Legal Officer A. Robert D. Bailey acquired an equity award of 52,570 restricted share units (RSUs) on common shares at a stated price of $0.00 per share. These RSUs were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.
The RSUs are scheduled to vest one-third on each of the first three anniversaries of the grant date, generally requiring Mr. Bailey’s continued service. After this award, his direct holdings in common shares total 223,146 shares, highlighting ongoing stock-based compensation tied to long-term service.